Cover Image
Market Research Report
Product code 
1093037

LAMEA Sepsis Diagnostics Market Size, Share & Industry Trends Analysis Report By Method, By Test Type, By Pathogen, By Product, By End-User, By Technology, By Country and Growth Forecast, 2022 - 2028

Published: | KBV Research | 142 Pages | Delivery time: 1-2 business days

Price

Back to Top
LAMEA Sepsis Diagnostics Market Size, Share & Industry Trends Analysis Report By Method, By Test Type, By Pathogen, By Product, By End-User, By Technology, By Country and Growth Forecast, 2022 - 2028
Published: April 29, 2022
KBV Research
Content info: 142 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The Latin America, Middle East and Africa Sepsis Diagnostics Market would witness market growth of 14.0% CAGR during the forecast period (2022-2028).

Children account for a significant proportion of the total instances of sepsis diagnosed each year, leading to a considerable number of deaths annually, the majority of which might be avoided with early identification and adequate clinical therapy. Diarrheal illnesses or respiratory illnesses are frequently the cause of these deaths. Obstetric infections, such as infections after an abortion or infections after a caesarean section, are the third leading cause of maternal death.

Biosensors that monitor biological or chemical interactions are frequently used to diagnose sepsis. Biosensors are devices that produce a signal proportional to analyses concentrations in biological samples. Biosensors are made up of a variety of components, including analyses, bio receptors, signal transducers, and display panels. Biosensors can identify low signals in a range of biological fluids using a minimal number of samples. Nanotechnology-based biosensors offer a revolutionary diagnostic technique that improves biomarker sensitivity and processing speed without requiring professional abilities. Biomarkers are frequently used in sepsis management for diagnostic, monitoring, prognostic, surrogate, and stratification purposes. PCT, CRP, and Interleukin-6 are three biomarkers that have proven useful in the clinical diagnosis of sepsis.

There is a significant prevalence of sepsis in Africa. According to the African Sepsis Alliance, in Africa, at least 2 million people die from sepsis each year. In addition, these figures, however, are likely to be grossly underestimated, because sepsis is rarely identified, recognized, or recorded as a cause of death in Africa. Sepsis is the third leading cause of maternal death, contributing to 11% of all maternal fatalities. Africa is predicted to have a greater incidence of maternal deaths due to sepsis, which accounts for two-thirds of infant deaths. Moreover, sepsis is a major public health issue that affects people in this region.

In well-resourced healthcare systems, there is substantial research into techniques to improve survival. Furthermore, since its beginning, the Enduring Sepsis Campaign has succeeded in elevating the profile of sepsis by raising awareness and offering evidence-based recommendations for optimal management, education, and performance improvement.

The Brazil market dominated the LAMEA Sepsis Diagnostics Market by Country in 2021, and would continue to be a dominant market till 2018; thereby, achieving a market value of $20.7 million by 2028. The Argentina market is anticipated to grow at a CAGR of 14.6% during (2022 - 2028). Additionally, The UAE market would experience a CAGR of 13.7% during (2022 - 2028).

Based on Method, the market is segmented into Conventional and Automated. Based on Test Type, the market is segmented into Laboratory Tests and Point-of-Care Tests. Based on Pathogen, the market is segmented into Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, and Others. Based on Product, the market is segmented into Blood Culture Media, Assays & Reagents, Instruments, and Software. Based on End-User, the market is segmented into Hospitals & specialty clinics, Pathology & Reference Laboratories, and Research Laboratories & Academic Institutes. Based on Technology, the market is segmented into Blood Culture, Immunoassays, Molecular Diagnostics, Flow Cytometry, Microfluidics, and Biomarkers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMerieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Thermo Fisher Scientific, Inc., DiaSorin S.p.A., Bruker Corporation, Siemens Healthineers AG, Danaher Corporation, and Quidel Corporation.

Scope of the Study

Market Segments covered in the Report:

By Method

  • Conventional
  • Automated

By Test Type

  • Laboratory Tests
  • Point-of-Care Tests

By Pathogen

  • Bacterial Sepsis
  • Fungal Sepsis
  • Viral Sepsis
  • Others

By Product

  • Blood Culture Media
  • Assays & Reagents
  • Instruments
  • Software

By End-User

  • Hospitals & specialty clinics
  • Pathology & Reference Laboratories
  • Research Laboratories & Academic Institutes

By Technology

  • Blood Culture
  • Immunoassays
  • Molecular Diagnostics
  • Flow Cytometry
  • Microfluidics
  • Biomarkers

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • BioMerieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • DiaSorin S.p.A.
  • Bruker Corporation
  • Siemens Healthineers AG
  • Danaher Corporation
  • Quidel Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Sepsis Diagnostics Market, by Method
    • 1.4.2 LAMEA Sepsis Diagnostics Market, by Test Type
    • 1.4.3 LAMEA Sepsis Diagnostics Market, by Pathogen
    • 1.4.4 LAMEA Sepsis Diagnostics Market, by Product
    • 1.4.5 LAMEA Sepsis Diagnostics Market, by End-User
    • 1.4.6 LAMEA Sepsis Diagnostics Market, by Technology
    • 1.4.7 LAMEA Sepsis Diagnostics Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
    • 3.2.4 Approvals and Trials
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul - 2021, Dec) Leading Players

Chapter 4. LAMEA Sepsis Diagnostics Market by Method

  • 4.1 LAMEA Conventional Market by Country
  • 4.2 LAMEA Automated Market by Country

Chapter 5. LAMEA Sepsis Diagnostics Market by Test Type

  • 5.1 LAMEA Laboratory Tests Market by Country
  • 5.2 LAMEA Point-of-Care Tests Market by Country

Chapter 6. LAMEA Sepsis Diagnostics Market by Pathogen

  • 6.1 LAMEA Bacterial Sepsis Market by Country
  • 6.2 LAMEA Fungal Sepsis Market by Country
  • 6.3 LAMEA Viral Sepsis Market by Country
  • 6.4 LAMEA Others Market by Country

Chapter 7. LAMEA Sepsis Diagnostics Market by Product

  • 7.1 LAMEA Blood Culture Media Market by Country
  • 7.2 LAMEA Assays & Reagents Market by Country
  • 7.3 LAMEA Instruments Market by Country
  • 7.4 LAMEA Software Market by Country

Chapter 8. LAMEA Sepsis Diagnostics Market by End-User

  • 8.1 LAMEA Hospitals & specialty clinics Market by Country
  • 8.2 LAMEA Pathology & Reference Laboratories Market by Country
  • 8.3 LAMEA Research Laboratories & Academic Institutes Market by Country

Chapter 9. LAMEA Sepsis Diagnostics Market by Technology

  • 9.1 LAMEA Blood Culture Market by Country
  • 9.2 LAMEA Immunoassays Market by Country
  • 9.3 LAMEA Molecular Diagnostics Market by Country
  • 9.4 LAMEA Flow Cytometry Market by Country
  • 9.5 LAMEA Microfluidics Market by Country
  • 9.6 LAMEA Biomarkers Market by Country

Chapter 10. LAMEA Sepsis Diagnostics Market by Country

  • 10.1 Brazil Sepsis Diagnostics Market
    • 10.1.1 Brazil Sepsis Diagnostics Market by Method
    • 10.1.2 Brazil Sepsis Diagnostics Market by Test Type
    • 10.1.3 Brazil Sepsis Diagnostics Market by Pathogen
    • 10.1.4 Brazil Sepsis Diagnostics Market by Product
    • 10.1.5 Brazil Sepsis Diagnostics Market by End-User
    • 10.1.6 Brazil Sepsis Diagnostics Market by Technology
  • 10.2 Argentina Sepsis Diagnostics Market
    • 10.2.1 Argentina Sepsis Diagnostics Market by Method
    • 10.2.2 Argentina Sepsis Diagnostics Market by Test Type
    • 10.2.3 Argentina Sepsis Diagnostics Market by Pathogen
    • 10.2.4 Argentina Sepsis Diagnostics Market by Product
    • 10.2.5 Argentina Sepsis Diagnostics Market by End-User
    • 10.2.6 Argentina Sepsis Diagnostics Market by Technology
  • 10.3 UAE Sepsis Diagnostics Market
    • 10.3.1 UAE Sepsis Diagnostics Market by Method
    • 10.3.2 UAE Sepsis Diagnostics Market by Test Type
    • 10.3.3 UAE Sepsis Diagnostics Market by Pathogen
    • 10.3.4 UAE Sepsis Diagnostics Market by Product
    • 10.3.5 UAE Sepsis Diagnostics Market by End-User
    • 10.3.6 UAE Sepsis Diagnostics Market by Technology
  • 10.4 Saudi Arabia Sepsis Diagnostics Market
    • 10.4.1 Saudi Arabia Sepsis Diagnostics Market by Method
    • 10.4.2 Saudi Arabia Sepsis Diagnostics Market by Test Type
    • 10.4.3 Saudi Arabia Sepsis Diagnostics Market by Pathogen
    • 10.4.4 Saudi Arabia Sepsis Diagnostics Market by Product
    • 10.4.5 Saudi Arabia Sepsis Diagnostics Market by End-User
    • 10.4.6 Saudi Arabia Sepsis Diagnostics Market by Technology
  • 10.5 South Africa Sepsis Diagnostics Market
    • 10.5.1 South Africa Sepsis Diagnostics Market by Method
    • 10.5.2 South Africa Sepsis Diagnostics Market by Test Type
    • 10.5.3 South Africa Sepsis Diagnostics Market by Pathogen
    • 10.5.4 South Africa Sepsis Diagnostics Market by Product
    • 10.5.5 South Africa Sepsis Diagnostics Market by End-User
    • 10.5.6 South Africa Sepsis Diagnostics Market by Technology
  • 10.6 Nigeria Sepsis Diagnostics Market
    • 10.6.1 Nigeria Sepsis Diagnostics Market by Method
    • 10.6.2 Nigeria Sepsis Diagnostics Market by Test Type
    • 10.6.3 Nigeria Sepsis Diagnostics Market by Pathogen
    • 10.6.4 Nigeria Sepsis Diagnostics Market by Product
    • 10.6.5 Nigeria Sepsis Diagnostics Market by End-User
    • 10.6.6 Nigeria Sepsis Diagnostics Market by Technology
  • 10.7 Rest of LAMEA Sepsis Diagnostics Market
    • 10.7.1 Rest of LAMEA Sepsis Diagnostics Market by Method
    • 10.7.2 Rest of LAMEA Sepsis Diagnostics Market by Test Type
    • 10.7.3 Rest of LAMEA Sepsis Diagnostics Market by Pathogen
    • 10.7.4 Rest of LAMEA Sepsis Diagnostics Market by Product
    • 10.7.5 Rest of LAMEA Sepsis Diagnostics Market by End-User
    • 10.7.6 Rest of LAMEA Sepsis Diagnostics Market by Technology

Chapter 11. Company Profiles

  • 11.1 BioMerieux S.A.
    • 11.1.1 Company Overview
    • 11.1.2 Financial Analysis
    • 11.1.3 Segmental and Regional Analysis
    • 11.1.4 Research & Development Expenses
    • 11.1.5 Recent strategies and developments:
      • 11.1.5.1 Acquisition and Mergers:
  • 11.2 F. Hoffmann-La Roche Ltd.
    • 11.2.1 Company Overview
    • 11.2.2 Financial Analysis
    • 11.2.3 Segmental and Regional Analysis
    • 11.2.4 Research & Development Expense
    • 11.2.5 Recent strategies and developments:
      • 11.2.5.1 Partnerships, Collaborations, and Agreements:
      • 11.2.5.2 Approvals and Trials:
  • 11.3 Becton, Dickinson and Company
    • 11.3.1 Company Overview
    • 11.3.2 Financial Analysis
    • 11.3.3 Segmental and Regional Analysis
    • 11.3.4 Research & Development Expense
    • 11.3.5 Recent strategies and developments:
      • 11.3.5.1 Product Launches and Product Expansions:
  • 11.4 Abbott Laboratories
    • 11.4.1 Company Overview
    • 11.4.2 Financial Analysis
    • 11.4.3 Segmental and Regional Analysis
    • 11.4.4 Research & Development Expense
    • 11.4.5 Recent strategies and developments:
      • 11.4.5.1 Acquisition and Mergers:
  • 11.5 Thermo Fisher Scientific, Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Financial Analysis
    • 11.5.3 Segmental and Regional Analysis
    • 11.5.4 Research & Development Expense
    • 11.5.5 Recent strategies and developments:
      • 11.5.5.1 Partnerships, Collaborations, and Agreements:
      • 11.5.5.2 Approvals and Trials:
      • 11.5.5.3 Acquisition and Mergers:
    • 11.5.6 SWOT Analysis
  • 11.6 DiaSorin S.p.A. (Luminex Corporation)
    • 11.6.1 Company Overview
    • 11.6.2 Financial Analysis
    • 11.6.3 Regional Analysis
    • 11.6.4 Research & Development Expenses
    • 11.6.5 Recent strategies and developments:
      • 11.6.5.1 Acquisitions and Mergers:
  • 11.7 Bruker Corporation
    • 11.7.1 Company Overview
    • 11.7.2 Financial Analysis
    • 11.7.3 Segmental and Regional Analysis
    • 11.7.4 Research & Development Expense
    • 11.7.5 Recent strategies and developments:
      • 11.7.5.1 Product Launches and Product Expansions:
      • 11.7.5.2 Acquisition and Mergers:
  • 11.8 Siemens Healthineers AG (Siemens AG)
    • 11.8.1 Company Overview
    • 11.8.2 Financial Analysis
    • 11.8.3 Segmental and Regional Analysis
    • 11.8.4 Research & Development Expenses
    • 11.8.5 Recent strategies and developments:
      • 11.8.5.1 Partnerships, Collaborations, and Agreements:
      • 11.8.5.2 Acquisition and Mergers:
  • 11.9 Danaher Corporation
    • 11.9.1 Company Overview
    • 11.9.2 Financial Analysis
    • 11.9.3 Segmental and Regional Analysis
    • 11.9.4 Research & Development Expense
  • 11.10. Quidel Corporation
    • 11.10.1 Company Overview
    • 11.10.2 Financial Analysis
    • 11.10.3 Regional Analysis
    • 11.10.4 Research & Development Expense
    • 11.10.5 Recent strategies and developments:
      • 11.10.5.1 Acquisition and Mergers:

LIST OF TABLES

  • TABLE 1 LAMEA Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 2 LAMEA Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements - Sepsis Diagnostics Market
  • TABLE 4 Product Launches And Product Expansions - Sepsis Diagnostics Market
  • TABLE 5 Acquisition and Mergers - Sepsis Diagnostics Market
  • TABLE 6 Approvals and Trials - Sepsis Diagnostics Market
  • TABLE 7 LAMEA Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 8 LAMEA Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 9 LAMEA Conventional Market by Country, 2018 - 2021, USD Million
  • TABLE 10 LAMEA Conventional Market by Country, 2022 - 2028, USD Million
  • TABLE 11 LAMEA Automated Market by Country, 2018 - 2021, USD Million
  • TABLE 12 LAMEA Automated Market by Country, 2022 - 2028, USD Million
  • TABLE 13 LAMEA Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 14 LAMEA Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 15 LAMEA Laboratory Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 16 LAMEA Laboratory Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 17 LAMEA Point-of-Care Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 18 LAMEA Point-of-Care Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 19 LAMEA Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 20 LAMEA Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 21 LAMEA Bacterial Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 22 LAMEA Bacterial Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 23 LAMEA Fungal Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 24 LAMEA Fungal Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 25 LAMEA Viral Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 26 LAMEA Viral Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 27 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 28 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 29 LAMEA Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 30 LAMEA Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 31 LAMEA Blood Culture Media Market by Country, 2018 - 2021, USD Million
  • TABLE 32 LAMEA Blood Culture Media Market by Country, 2022 - 2028, USD Million
  • TABLE 33 LAMEA Assays & Reagents Market by Country, 2018 - 2021, USD Million
  • TABLE 34 LAMEA Assays & Reagents Market by Country, 2022 - 2028, USD Million
  • TABLE 35 LAMEA Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 36 LAMEA Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 37 LAMEA Software Market by Country, 2018 - 2021, USD Million
  • TABLE 38 LAMEA Software Market by Country, 2022 - 2028, USD Million
  • TABLE 39 LAMEA Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 40 LAMEA Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 41 LAMEA Hospitals & specialty clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 42 LAMEA Hospitals & specialty clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 43 LAMEA Pathology & Reference Laboratories Market by Country, 2018 - 2021, USD Million
  • TABLE 44 LAMEA Pathology & Reference Laboratories Market by Country, 2022 - 2028, USD Million
  • TABLE 45 LAMEA Research Laboratories & Academic Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 46 LAMEA Research Laboratories & Academic Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 47 LAMEA Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 48 LAMEA Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 49 LAMEA Blood Culture Market by Country, 2018 - 2021, USD Million
  • TABLE 50 LAMEA Blood Culture Market by Country, 2022 - 2028, USD Million
  • TABLE 51 LAMEA Immunoassays Market by Country, 2018 - 2021, USD Million
  • TABLE 52 LAMEA Immunoassays Market by Country, 2022 - 2028, USD Million
  • TABLE 53 LAMEA Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 54 LAMEA Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 55 LAMEA Flow Cytometry Market by Country, 2018 - 2021, USD Million
  • TABLE 56 LAMEA Flow Cytometry Market by Country, 2022 - 2028, USD Million
  • TABLE 57 LAMEA Microfluidics Market by Country, 2018 - 2021, USD Million
  • TABLE 58 LAMEA Microfluidics Market by Country, 2022 - 2028, USD Million
  • TABLE 59 LAMEA Biomarkers Market by Country, 2018 - 2021, USD Million
  • TABLE 60 LAMEA Biomarkers Market by Country, 2022 - 2028, USD Million
  • TABLE 61 LAMEA Sepsis Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 62 LAMEA Sepsis Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 63 Brazil Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 64 Brazil Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 65 Brazil Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 66 Brazil Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 67 Brazil Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 68 Brazil Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 69 Brazil Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 70 Brazil Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 71 Brazil Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 72 Brazil Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 73 Brazil Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 74 Brazil Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 75 Brazil Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 76 Brazil Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 77 Argentina Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 78 Argentina Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 79 Argentina Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 80 Argentina Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 81 Argentina Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 82 Argentina Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 83 Argentina Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 84 Argentina Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 85 Argentina Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 86 Argentina Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 87 Argentina Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 88 Argentina Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 89 Argentina Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 90 Argentina Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 91 UAE Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 92 UAE Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 93 UAE Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 94 UAE Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 95 UAE Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 96 UAE Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 97 UAE Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 98 UAE Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 99 UAE Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 100 UAE Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 101 UAE Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 102 UAE Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 103 UAE Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 104 UAE Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 105 Saudi Arabia Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 106 Saudi Arabia Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 107 Saudi Arabia Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 108 Saudi Arabia Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 109 Saudi Arabia Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 110 Saudi Arabia Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 111 Saudi Arabia Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 112 Saudi Arabia Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 113 Saudi Arabia Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 114 Saudi Arabia Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 115 Saudi Arabia Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 116 Saudi Arabia Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 117 Saudi Arabia Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 118 Saudi Arabia Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 119 South Africa Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 120 South Africa Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 121 South Africa Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 122 South Africa Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 123 South Africa Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 124 South Africa Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 125 South Africa Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 126 South Africa Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 127 South Africa Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 128 South Africa Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 129 South Africa Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 130 South Africa Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 131 South Africa Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 132 South Africa Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 133 Nigeria Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 134 Nigeria Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 135 Nigeria Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 136 Nigeria Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 137 Nigeria Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 138 Nigeria Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 139 Nigeria Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 140 Nigeria Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 141 Nigeria Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 142 Nigeria Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 143 Nigeria Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 144 Nigeria Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 145 Nigeria Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 146 Nigeria Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 147 Rest of LAMEA Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 148 Rest of LAMEA Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 149 Rest of LAMEA Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 150 Rest of LAMEA Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 151 Rest of LAMEA Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 152 Rest of LAMEA Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 153 Rest of LAMEA Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 154 Rest of LAMEA Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 155 Rest of LAMEA Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 156 Rest of LAMEA Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 157 Rest of LAMEA Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 158 Rest of LAMEA Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 159 Rest of LAMEA Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 160 Rest of LAMEA Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 161 Key information - BioMerieux S.A.
  • TABLE 162 KEY INFORMATION - F. HOFFMANN-LA ROCHE LTD.
  • TABLE 163 Key information - Becton, Dickinson and Company
  • TABLE 164 Key Information - Abbott Laboratories
  • TABLE 165 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 166 Key Information - DiaSorin S.p.A.
  • TABLE 167 Key Information - Bruker Corporation
  • TABLE 168 Key Information - Siemens Healthineers AG
  • TABLE 169 Key Information - Danaher Corporation
  • TABLE 170 key information - Quidel Corporation

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul - 2021, Dec) Leading Players
  • FIG 5 Recent strategies and developments: Thermo Fisher Scientific, Inc.
  • FIG 6 Swot analysis: thermo fisher scientific, inc.
  • FIG 7 Recent strategies and developments: Bruker Corporation